Fingerprint
Dive into the research topics of 'A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nils Koch-Henriksen*, Melinda Magyari, Finn Sellebjerg, Per Soelberg Sørensen